Are you an early career scientist looking to launch your career in pain research? Then be sure to submit your innovative research project in the area of chronic pain to be considered for a research grant from this prestigious scheme!
The E-G-G is awarded by the European Pain Federation (EFIC) and sponsored by the pharmaceutical company Grünenthal GmbH. Since 2004, it has provided funding worth approximately €1.8 million for 70 innovative research projects across 14 countries. Grünenthal supports the E-G-G 2023 with a maximum of €110,000, and each grant will have a maximum value of €50,000.
The aim of the E-G-G is to provide early-career scientists and clinicians in EFIC member countries with support in starting independent clinical and human experimental research projects in the area of chronic pain, including educational initiatives aimed at improving diagnosis and treatment. In particular, the E-G-G prioritizes translational research projects that take a patient-centric approach and target unmet medical needs for people with chronic pain.
The deadline for applications is 31 January 2023.